• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米拉贝隆可缓解创伤性三叉神经神经病模型小鼠的痛觉过敏而不引起镇静。

Mirogabalin alleviates nociceptive hypersensitivity without causing sedation in a mouse model of post-traumatic trigeminal neuropathy.

机构信息

Department of Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan; Department of Dental Anesthesiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.

Department of Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.

出版信息

Behav Brain Res. 2022 May 3;425:113829. doi: 10.1016/j.bbr.2022.113829. Epub 2022 Mar 3.

DOI:10.1016/j.bbr.2022.113829
PMID:35248649
Abstract

Post-traumatic trigeminal neuropathy (PTTN) is a chronic sensory disorder that afflicts patients with nerve injury caused by orofacial and dental surgery or cervicofacial trauma. Currently, effective treatment strategies for PTTN are lacking, and patients treated with conventional drugs for PTTN experience adverse effects such as drowsiness and drug addiction. In the present study, we investigated whether mirogabalin, a novel gabapentinoid, could be an effective treatment for PTTN induced by distal infraorbital nerve chronic constriction injury (dIoN-CCI) in the mouse. Increased facial grooming time and hyper-responsiveness to acetone were observed in dIoN-CCI mice. These pain-related behaviors were attenuated by intraperitoneal injection of mirogabalin. In particular, mirogabalin significantly diminished the increase in facial grooming time. The analgesic effect of mirogabalin injection started 45 min after the injection and persisted for 6 h. Additionally, 10 mg/kg mirogabalin did not affect locomotor activity in the open field test, suggesting that it does not cause sedation. Together, the current findings suggest that mirogabalin could be a valuable therapeutic drug for PTTN following orofacial surgeries without sedative side effects.

摘要

创伤后三叉神经感觉根神经病(PTTN)是一种慢性感觉障碍,影响因口腔颌面和牙科手术或头颈部创伤导致神经损伤的患者。目前,PTTN 的有效治疗策略缺乏,接受 PTTN 常规药物治疗的患者会出现嗜睡和药物成瘾等不良反应。在本研究中,我们研究了新型加巴喷丁类药物米罗加巴林是否可有效治疗小鼠眶下神经远端慢性缩窄性损伤(dIoN-CCI)引起的 PTTN。dIoN-CCI 小鼠表现出面部梳理时间增加和对丙酮的超敏反应。腹腔注射米罗加巴林可减轻这些与疼痛相关的行为。特别是,米罗加巴林显著减少了面部梳理时间的增加。米罗加巴林注射后的镇痛作用在注射后 45 分钟开始,并持续 6 小时。此外,10mg/kg 的米罗加巴林不会影响旷场试验中的运动活动,提示其不会引起镇静作用。综上所述,这些发现表明米罗加巴林可能是一种治疗口腔颌面手术后 PTTN 的有价值药物,无镇静副作用。

相似文献

1
Mirogabalin alleviates nociceptive hypersensitivity without causing sedation in a mouse model of post-traumatic trigeminal neuropathy.米拉贝隆可缓解创伤性三叉神经神经病模型小鼠的痛觉过敏而不引起镇静。
Behav Brain Res. 2022 May 3;425:113829. doi: 10.1016/j.bbr.2022.113829. Epub 2022 Mar 3.
2
Pretreatment with High Mobility Group Box-1 Monoclonal Antibody Prevents the Onset of Trigeminal Neuropathy in Mice with a Distal Infraorbital Nerve Chronic Constriction Injury.用高迁移率族蛋白B1单克隆抗体预处理可预防患有眶下神经远端慢性压迫性损伤小鼠的三叉神经病变发作。
Molecules. 2021 Apr 2;26(7):2035. doi: 10.3390/molecules26072035.
3
Perineural Treatment with High Mobility Group Box-1 Monoclonal Antibody Prevents Initiation of Pain-Like Behaviors in Female Mice with Trigeminal Neuropathy.高迁移率族蛋白 B1 单克隆抗体经神经周治疗可预防三叉神经病变雌性小鼠疼痛样行为的发生。
Biol Pharm Bull. 2024;47(1):221-226. doi: 10.1248/bpb.b23-00729.
4
Anxiolytic effects of the novel αδ ligand mirogabalin in a rat model of chronic constriction injury, an experimental model of neuropathic pain.新型 αδ 配体米罗加巴林在慢性缩窄性损伤大鼠模型中的抗焦虑作用,一种神经病理性疼痛的实验模型。
Psychopharmacology (Berl). 2020 Jan;237(1):189-197. doi: 10.1007/s00213-019-05356-3. Epub 2019 Sep 12.
5
Analgesic effects of the novel α₂δ ligand mirogabalin in a rat model of spinal cord injury.新型α₂δ配体米罗加巴林在大鼠脊髓损伤模型中的镇痛作用
Pharmazie. 2018 Nov 1;73(11):659-661. doi: 10.1691/ph.2018.8550.
6
Mirogabalin as a Therapeutic Option for Neuropathic Pain Emerging Post-endodontic Treatment: A Two-Case Report.米罗加巴林作为牙髓治疗后出现神经病理性疼痛的治疗选择:两例报告。
J Endod. 2024 Sep;50(9):1351-1356. doi: 10.1016/j.joen.2024.06.007. Epub 2024 Jun 18.
7
Unilateral facial injection of Botulinum neurotoxin A attenuates bilateral trigeminal neuropathic pain and anxiety-like behaviors through inhibition of TLR2-mediated neuroinflammation in mice.单侧面部注射肉毒杆菌神经毒素 A 通过抑制 TLR2 介导的神经炎症,减轻小鼠双侧三叉神经病理性疼痛和焦虑样行为。
J Headache Pain. 2021 May 17;22(1):38. doi: 10.1186/s10194-021-01254-2.
8
Neuropathic orofacial pain: Facts and fiction.神经性口面部疼痛:事实与虚构
Cephalalgia. 2017 Jun;37(7):670-679. doi: 10.1177/0333102417706310. Epub 2017 Apr 12.
9
Anti-nociceptive effects of ECa 233 a standardized extract of Centella asiatica (L.) Urban on chronic neuropathic orofacial pain in mice.积雪草(Centella asiatica(L.)Urban)标准化提取物 ECa 233 对慢性神经性口面痛小鼠的抗伤害作用。
J Ethnopharmacol. 2022 Jan 30;283:114737. doi: 10.1016/j.jep.2021.114737. Epub 2021 Oct 11.
10
Analgesic effects of mirogabalin, a novel ligand for αδ subunit of voltage-gated calcium channels, in experimental animal models of fibromyalgia.米拉贝隆(mirogabalin)在电压门控钙通道 αδ 亚基配体的新型配体,在纤维肌痛的实验动物模型中的镇痛作用。
Naunyn Schmiedebergs Arch Pharmacol. 2019 Jun;392(6):723-728. doi: 10.1007/s00210-019-01628-z. Epub 2019 Feb 15.

引用本文的文献

1
Mirogabalin Decreases Pain-like Behaviors by Inhibiting the Microglial/Macrophage Activation, p38MAPK Signaling, and Pronociceptive CCL2 and CCL5 Release in a Mouse Model of Neuropathic Pain.在神经性疼痛小鼠模型中,米罗加巴林通过抑制小胶质细胞/巨噬细胞激活、p38丝裂原活化蛋白激酶信号传导以及伤害感受性趋化因子CCL2和CCL5的释放来减轻疼痛样行为。
Pharmaceuticals (Basel). 2023 Jul 19;16(7):1023. doi: 10.3390/ph16071023.
2
Effects of Mirogabalin on Hyperalgesia and Chronic Ocular Pain in Tear-Deficient Dry-Eye Rats.米拉贝隆对泪液缺乏性干眼症大鼠痛觉过敏和慢性眼部疼痛的影响。
Invest Ophthalmol Vis Sci. 2023 May 1;64(5):27. doi: 10.1167/iovs.64.5.27.